Home/Allterum Therapeutics/Yan Moore, MD, MBA
YM

Yan Moore, MD, MBA

Chief Executive Officer

Allterum Therapeutics

Allterum Therapeutics Pipeline

DrugIndicationPhase
4A10Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (ALL)Pre-clinical